Medicines and Pregnancy Registry

NHS Digital is working in partnership with the Medicines and Healthcare products Regulatory Agency (MHRA) to develop comprehensive national Medicines in Pregnancy Registries which can give a better understanding of the use, benefits, and risks of medicines taken in pregnancy.

This report is an analysis of existing administrative patient data as a proof of concept, to establish the use and value of these data sets in supporting robust and sustainable medicine registries. The data produced are designed to support the MHRA in monitoring the level of success of the valproate pregnancy prevention plan and to enable the wider health and care system to further understand outcomes for women prescribed antiepileptics during pregnancy and their children and consequently to improve patient care.